跳至主要内容
临床试验/JPRN-UMIN000021193
JPRN-UMIN000021193已完成未知

Study to evaluate the effectiveness and saftyof the mFOLFOX+bevacizumab combination therapy for bladder adenocarcinoma - Study to evaluate the effectiveness and saftyof the mFOLFOX+bevacizumab combination therapy for bladder adenocarcinoma

agoya City University Hospital0 个研究点目标入组 2 人开始时间: 2016年2月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Case with serious myelosuppression 2.Case with the diarrhea (stools watery) 3.Case who had a serious infection 4.A large quantity of ascitic fluid, case with the pleural effusion 5.Case with serious heart disease or the anamnesis 6.The case that overall status worsens 7.Case with severe dysesthesia with the functional disorder or the dysesthesia 8.A pregnant woman or the case that may be pregnant and nursing mother 9.It is a case with a history of hypersensitivity for an ingredient including, levofolinate, fluorouracil, oxaliplatin and other platinum

研究者

发起方
agoya City University Hospital

相似试验

Study to evaluate the effectiveness and saftyof the... | 临床试验